In a recent trial of 78 melanoma patients harboring KIT alterations, the median overall survival for imatinib is 13.1 months and the objective response rate is 21.8% (149)
Its important to note that these are average results, and individual responses vary significantly
Generally, Ozempic injections arent very painful because they are subcutaneous injections that go just below the surface of the skin using a thin, short needle ( 4 mm long , which is about one-sixth of an inch)
rather, it takes time to see results
According to the Web of Science citation index, the retracted work has been cited 577 times
Before initiating JANUVIA, ask patients about a history of heart failure or other risk factors for heart failure including moderate to severe renal impairment